Eu Construction Products Regulation CE Marking Services
EU Construction Products Regulation (CPR) CE marking is not a single certificate or a one-step filing. A defensible project starts by identifying the technical specification and the CPR regime that actually applies to the product, then allocates testing, factory production control and third-party tasks, builds the technical file, issues the required declaration, and releases the CE marking only when the evidence chain is complete. In 2026 this route-selection step is especially important because Regulation (EU) No 305/2011 and Regulation (EU) 2024/3110 coexist during a product-family-by-product-family transition.
Start with the route gate before ordering tests
The first deliverable should be a route memo, not a laboratory booking. A construction product may fall within the broad CPR field without yet being subject to a particular harmonised CE-marking route. The legally relevant question is whether the product and its declared use are covered by an applicable harmonised technical specification or, where appropriate, by the European Technical Assessment route.
| Route gate | What must be verified | Operational output |
|---|---|---|
| Product and intended use | Product description, composition, variants, intended permanent incorporation into construction works, and the use that will be declared. | Controlled product scope and product-type/variant map. |
| CPR transition status | Whether the relevant product family is still operating under a harmonised standard retained under Regulation (EU) No 305/2011, or has moved to requirements under Regulation (EU) 2024/3110. | Applicable-regime record with the OJEU reference and transition basis. |
| Technical route | Applicable harmonised standard or harmonised technical specification; if no suitable harmonised standard route exists, whether a European Assessment Document and European Technical Assessment route is available or appropriate. | Standard/ETA route decision and list of applicable essential characteristics. |
| Assessment system | The AVCP/AVS system applicable to the product, intended use and characteristics, including which tasks belong to the manufacturer and which require a notified body. | Responsibility matrix and third-party scope. |
| Target markets | Languages, national rules on the use of construction products, and any performance levels needed for the intended application. | Market-readiness criteria by destination without inventing additional EU CE tests. |
Under the current transition, harmonised standards cited under the 2011 CPR and still in force on 8 January 2026 remain valid under that regime until withdrawn or otherwise repealed. For a product family migrating to CPR-2024, the new requirements and economic-operator obligations generally become applicable according to the transition mechanism in Article 95 of Regulation (EU) 2024/3110. This is why a generic statement that “the new CPR applies to every construction product now” is unsafe.
End-to-end execution workflow
- Intake and product freeze. Collect drawings, bill of materials, formulations, manufacturing sites, variants, intended uses, existing reports, certificates, declarations, quality-control procedures and target EU/EEA markets. Identify what is fixed and what is still changing.
- Regulatory and technical specification mapping. Confirm the applicable CPR route, the OJEU-cited standard or other harmonised technical specification, any relevant EAD/ETA path, the essential characteristics to be declared and the applicable assessment system.
- Evidence-gap plan. Map each required characteristic to existing evidence, new testing, calculation, classification, tabulated values or other method permitted by the applicable specification. Reject legacy reports that do not match the current product type, method or scope.
- Provider appointment. Where third-party involvement is required, select a notified body whose notified scope covers the relevant legislation, product/specification and task. For an ETA route, select a competent Technical Assessment Body (TAB) for the relevant product area. A service coordinator can manage the process, but cannot replace a legally required notified body or TAB.
- Testing and factory production control. Execute the prescribed tests/assessments and implement or align factory production control. Keep sample identity, variant coverage, production site and test method traceable to the product type that will be declared.
- Technical documentation. Assemble the technical basis for the declaration: product identification, intended use, applicable specification, assessment-system record, test/calculation evidence, notified-body or TAB documents where applicable, production-control evidence, instructions and safety/product information required by the governing route.
- Declaration and CE marking. Under the applicable legacy route this normally means a Declaration of Performance (DoP); under CPR-2024 the instrument is the Declaration of Performance and Conformity (DoPC). The CE marking is affixed only after the applicable declaration and supporting technical documentation are in place.
- Release and change control. Verify label/marking content, language versions, document availability, importer/distributor handoff and destination-use requirements. Establish triggers for reassessment when the product, raw materials, process, plant, supplier, intended use or technical specification changes.
Who owns each part of the file
| Actor | Core responsibility in the execution chain | What the project should obtain |
|---|---|---|
| Manufacturer | Defines the product placed on the market, maintains the production-control system, holds the technical basis and assumes the regulatory responsibility attached to the declaration and CE marking. | Approved product definition, manufacturer decisions, FPC evidence, signed declaration and release approval. |
| Compliance/service coordinator | Builds the route map, controls document flow, coordinates laboratories, notified bodies/TABs and closes evidence gaps. This is a project role, not a substitute for statutory responsibilities. | Route memo, evidence matrix, provider brief, document index, issue log and launch checklist. |
| Testing laboratory / notified body | Performs only the testing, assessment, certification or verification tasks within its competent/notified scope and the applicable assessment system. | Traceable reports, certificates or validation outputs that identify the product, method, scope and relevant site where required. |
| Technical Assessment Body | Handles the ETA process where that route is used, on the basis of an applicable EAD or the procedure for developing one. | ETA and associated technical basis where the route is successfully completed. |
| Importer / distributor | Performs the checks and supply-chain duties assigned by the applicable CPR framework before making the product available. | Correct CE/document package, traceability information and escalation route for non-conformity. |
Document flow and release criteria
| Stage | Minimum controlled inputs | Deliverable | Do not release if… |
|---|---|---|---|
| Route definition | Product description, intended use, markets, current OJEU references. | Applicable-route memo. | The standard/ETA basis is guessed, outdated or does not cover the declared use. |
| Test planning | Essential characteristics, assessment system, product variants, existing evidence. | Test/evidence matrix and sample plan. | Variant coverage, sampling responsibility or notified-body involvement is unresolved. |
| Assessment | Controlled samples, current methods, FPC/process information. | Reports/certificates/ETA outputs. | Reports identify a different product type, site, method or revision without a justified bridge. |
| Technical file | All accepted evidence and controlled product data. | Indexed technical documentation and draft declaration. | Evidence cannot be traced from declared characteristic to source report or calculation. |
| Market release | Final declaration, CE marking artwork/data, instructions, required language set and supply-chain data. | Release pack and controlled master versions. | The declaration, CE information and product identifiers are inconsistent. |
Testing is a handoff, not the whole CE-marking project
The applicable specification determines which characteristics require testing, calculation, classification or other assessment and which tasks require a notified body. The project should therefore send the laboratory or notified body a controlled brief: exact product type, intended use, relevant standard/specification revision, characteristics, variants, sample identity, manufacturing site where relevant and the required output. Testing performed before the route is fixed can be unusable if the wrong method, product configuration or third-party role was chosen.
Detailed laboratory selection, sample strategy and retest logic belong on the EU Construction Products Regulation testing services page. This page owns the handoff: what must go into testing and what evidence must come back before the declaration can be completed.
What changes between the legacy CPR and CPR-2024
| Execution point | Legacy route still operating under Regulation (EU) No 305/2011 | CPR-2024 route when applicable to the product family |
|---|---|---|
| Main declaration | Declaration of Performance (DoP). | Declaration of Performance and Conformity (DoPC). |
| Assessment framework | AVCP system under the applicable harmonised standard/ETA framework. | AVS framework under Regulation (EU) 2024/3110 and applicable product-family rules, including Delegated Regulation (EU) 2026/1310 where relevant. |
| Environmental information | Depends on the applicable legacy specification and legal requirements. | CPR-2024 introduces predetermined environmental essential characteristics and related assessment rules as the new system is rolled out. |
| Digital product passport | Not a legacy CPR requirement. | Part of the new architecture, but not a universal “day-one” requirement for every product; mandatory use is tied to implementing/delegated measures for the relevant product family. |
| Transition control | Continue using the valid 2011-CPR technical route while its OJEU reference remains applicable. | Switch only on the legally applicable timetable for the relevant product family/category or where the Regulation permits early use of the new harmonised technical specification. |
There is usually no central EU CE “filing” to wait for
For ordinary CPR CE marking, market readiness is not created by uploading an application to a single EU authority and waiting for an approval number. The manufacturer completes the applicable assessment route, obtains required third-party outputs, compiles the technical documentation, issues the applicable declaration and affixes the CE marking. Where a notified body is required, its certificate or validation is an input to that manufacturer-led release process. Where an ETA route is used, the TAB/EAD/ETA sequence is a separate technical-assessment path.
This distinction matters operationally: a project can be delayed even when all laboratory work is finished if the FPC evidence, declaration, product identifiers, notified-body scope or language package is still incomplete.
Market readiness is not the same as permission for every intended use
CE marking creates a harmonised way to express and verify product performance; it does not replace national rules governing the use or installation of construction products in works. Before launch, compare the declared performance with the requirements applicable to the intended use in the destination country. National Product Contact Points for Construction are an official route for obtaining information on those national rules.
Do not solve this by inventing country-specific “extra CE tests.” The correct task is to determine whether the declared performance satisfies the national use requirement while respecting the harmonised technical language.
Change-control map after CE marking
| Change event | Required control question | Typical project action |
|---|---|---|
| Raw material or critical supplier changes | Can the change affect a declared characteristic, product requirement or the validity of existing evidence? | Technical impact review; re-test/recalculation or notified-body consultation where required. |
| Design, geometry, formulation or variant changes | Does the modified item remain within the assessed product type and evidence envelope? | Update the product-type/variant map and reassess affected characteristics. |
| Production process or manufacturing site changes | Does the change affect FPC, sampling, certificate scope or performance? | Update FPC and notify/engage the certification body where its rules require it before release. |
| Standard/specification revision or CPR migration | Has the OJEU status, mandatory date or applicable assessment method changed? | Regulatory re-check, gap analysis, document revision and transition plan. |
| Complaint, non-conformity or surveillance finding | Is the declared performance or conformity no longer supported? | Contain affected product, investigate, correct documentation/production and take withdrawal or recall action where legally required. |
Common bottlenecks that should be closed before launch
- Wrong route: ordering tests to a familiar EN standard without proving that the product and declared use are within its scope.
- Wrong third party: using a laboratory or certification body that does not have the required notified scope for the task.
- Variant drift: test samples, production specification and marketed variants no longer match.
- Uncontrolled legacy evidence: old test reports are reused without checking method, product type, factory and transition validity.
- FPC lag: testing is complete but factory production control is not ready for the applicable assessment system.
- Declaration mismatch: characteristics, classes, identifiers or references in the declaration do not match the underlying reports and CE marking.
- Launch without national-use check: CE marking exists, but the declared performance does not meet the intended application requirement in the destination market.
Where this service ends and neighbouring work begins
This page covers execution and coordination from intake to a controlled release pack. If the unresolved issue is primarily product classification, regulatory strategy or whether a route applies at all, use the EU Construction Products Regulation consultant page. For laboratory evidence, sampling and retest design, use the CPR testing services page. For budgeting and cost drivers, use the CE marking cost page. For a broader cross-regime CE execution overview outside the CPR-specific workflow, see CE marking services.
Official sources
- Regulation (EU) 2024/3110 on construction products.
- European Commission — CPR 2024 revision and transition.
- European Commission — CE marking and Declaration of Performance and Conformity.
- European Commission — voluntary CE marking / EOTA route.
- Commission Delegated Regulation (EU) 2026/1310 on assessment and verification systems.
FAQ
Can a construction product be CE marked if there is no harmonised standard for it?
Not automatically. First confirm whether the product is covered by another applicable harmonised technical route. Where no suitable harmonised standard route exists, a voluntary European Technical Assessment route may be available for an eligible product through a Technical Assessment Body and an applicable or newly developed European Assessment Document. The route must be checked for the specific product and intended use.
Do we need a notified body for every CPR CE-marking project?
No. Third-party involvement depends on the applicable AVCP/AVS system and the tasks assigned by the relevant technical specification or assessment route. If a notified body is required, its notified scope must cover the relevant product/specification and task; a general ISO-accredited laboratory is not automatically a substitute.
Should we use Regulation (EU) No 305/2011 or Regulation (EU) 2024/3110 in 2026?
That cannot be decided by the calendar alone. During the transition, some product families continue under harmonised standards retained under the 2011 CPR, while CPR-2024 applies progressively as new harmonised technical specifications and the Article 95 transition mechanism take effect. Check the current OJEU status for the exact product family and intended use.
Is there an EU authority that approves our CE label before we sell?
Usually no. CPR CE marking is principally a manufacturer-led conformity and performance declaration process with notified-body or TAB involvement where the applicable route requires it. The manufacturer should not release the product until the required assessment outputs, technical documentation, declaration and CE marking information are complete and consistent.
Does CE marking mean the product can be used for any construction purpose in every EU country?
No. CE marking harmonises how performance is assessed and communicated, but Member States retain rules for construction works and for the conditions of use of products. The declared performance must therefore be checked against the requirements for the intended application in the destination market.
When does a product change require reassessment?
Reassessment is needed when a change can affect declared performance, conformity, the assessed product type or the validity of the applicable evidence. Design, material, supplier, process, manufacturing-site and technical-specification changes should all pass through documented change control before the modified product is released.